Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to find out the biochemical markers which have independent predictive value of fragility fractures risk with Type 2 diabetes in Guangzhou community and evaluate bone strength better and increase the ability of recognizing fracture risk through following-up visits the bone metabolism index like esRAGE-to-pentosidine ratio of the petients with type 2 diabetes and osteoporosis,compared with the classical fracture risk assessment instrument.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03456271
Study type Observational [Patient Registry]
Source Zhujiang Hospital
Contact
Status Terminated
Phase
Start date July 1, 2017
Completion date December 31, 2021